Tri-Hemic 60mg Tablets

184

Description

Tri-Hemic 600 Tablets Overview

Tri-Hemic 600 Tablets is also known as vitamin C. Tri-Hemic 600 Tablets is a water soluble vitamin. It is structurally related to monosaccharides and exists in nature in both a reduced and the oxidized form, dehydroit. It involves in different body functions. its supplements may be used in persons with chronic illness, burns, or certain blood disorders. Best sources of vitamin C is fresh fruits such as citrus fruits, strawberries, melons and leafy vegetables such as lettuce, cabbage and tomatoes, potatoes and green and red peppers.

Indications

Tri-Hemic 600 Tablets is primarily indicated in conditions like Prevention and treatment of scurvy, Scurvy, Vitamin deficiency.

Contraindication

Tri-Hemic 600 Tablets is contraindicated in conditions like Hyperoxaluria.

Side Effects

The severe or irreversible adverse effects of Tri-Hemic 600 Tablets, which give rise to further complications include Kidney oxalate stones.Tri-Hemic 600 Tablets produces potentially life-threatening effects which include Failure of conception, which are responsible for the discontinuation of Tri-Hemic 600 Tablets therapy. The signs and symptoms that are produced after the acute overdosage of Tri-Hemic 600 Tablets include Diarrhea, Gl disturbances, Hemolysis in patients with G6PD deficiency. The symptomatic adverse reactions produced by Tri-Hemic 600 Tablets are more or less tolerable and if they become severe, they can be treated symptomatically, these include Laxative effect.

Warnings

Tri-Hemic 600 Tablets should be used with caution (if contains tartarazine) in patients with aspirin hypersensitivity, because it may cause allergic reactions (including bronchial asthma). Use with caution in patients with glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. Avoid large dose of Tri-Hemic 600 Tablets, because it may cause renal calcium oxalate calculi.

 

Reviews

There are no reviews yet.

Be the first to review “Tri-Hemic 60mg Tablets”

Your email address will not be published. Required fields are marked *